MADRID, Nov 11 (Reuters) -Laboratorios Almirall (ALM.MC: Quote, Profile, Research, Stock Buzz) said on Tuesday that it would market in Spain in conjunction with Pfizer (PFE.N: Quote, Profile, Research, Stock Buzz) one of the U.S. firm’s drugs which reduces cardiovascular risk in patients with hypertension.
